PTC Therapeutics PTCT Business Segments — Segment Reporting Other Item Amount
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's business segments — segment reporting other item amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is PTC Therapeutics's business segments — segment reporting other item amount?
- PTC Therapeutics (PTCT) reported business segments — segment reporting other item amount of $107.89M in Q1 2026.
- How has PTC Therapeutics's business segments — segment reporting other item amount changed year-over-year?
- PTC Therapeutics's business segments — segment reporting other item amount decreased by 25.8% year-over-year, from $145.42M to $107.89M.
- What is the long-term trend for PTC Therapeutics's business segments — segment reporting other item amount?
- Over 3 years (2022 to 2025), PTC Therapeutics's business segments — segment reporting other item amount has grown at a -6.0% compound annual growth rate (CAGR), from $437.41M to $363.61M.
- What does business segments — segment reporting other item amount mean?
- This captures miscellaneous or non-recurring financial items specific to the life science segment that do not fit into standard operating expense categories. It is used to reconcile segment performance by accounting for unique adjustments, impairments, or one-time charges.